leading glp-1 treatments for diabetes 2025 Receptor Agonist Market Size Pharma Giants Bet on Next-Generation

Some research links it to reductions in visceral fat

Furthermore, it can promote plaque buildup which can damage and narrow arteries and increase blood pressure, leading to increased risks for developing cardiovascular diseases such as atherosclerosis and thrombosis

What is available right now looks different

Avoid GLP-1s if you have a multiple endocrine neoplasia syndrome type 2 (MEN2)

This occurs because appetite returns to pre-treatment levels and the body's metabolic adaptations to weight loss persist, making weight maintenance challenging without continued intervention

Offer additional support by sharing tips on diet, drinking water, and building healthy habits